ReP USP - Resultado da busca

Artigo de periodico
Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity (2024)
Nani, João Victor; Ushirohira, Juliana Mayumi; Bradshaw, Nicholas J.; Machado-de-Sousa, João Paulo ; Hallak, Jaime Eduardo Cecilio ; Hayashi, Mirian A.
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: ESQUIZOFRENIA, BIOMARCADORES, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NANI, João Victor et al. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity. Brazilian Journal of Psychiatry, 2024Tradução . . Disponível em: https://doi.org/10.47626/1516-4446-2023-3315. Acesso em: 04 nov. 2024.
APA
Nani, J. V., Ushirohira, J. M., Bradshaw, N. J., Machado-de-Sousa, J. P., Hallak, J. E. C., & Hayashi, M. A. (2024). Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity. Brazilian Journal of Psychiatry. doi:10.47626/1516-4446-2023-3315
NLM
Nani JV, Ushirohira JM, Bradshaw NJ, Machado-de-Sousa JP, Hallak JEC, Hayashi MA. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity [Internet]. Brazilian Journal of Psychiatry. 2024 ;[citado 2024 nov. 04 ] Available from: https://doi.org/10.47626/1516-4446-2023-3315
Vancouver
Nani JV, Ushirohira JM, Bradshaw NJ, Machado-de-Sousa JP, Hallak JEC, Hayashi MA. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity [Internet]. Brazilian Journal of Psychiatry. 2024 ;[citado 2024 nov. 04 ] Available from: https://doi.org/10.47626/1516-4446-2023-3315
Artigo de periodico
Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group (2023)
Wagner, Elias; Siskind, Dan; Falkai, Peter; Howes, Oliver; Correll, Christoph; Lee, Jimmy; Honer, William G.; Kane, John M.; Fernandez-Egea, Emilio; Barnes, Thomas R. E.; Hallak, Jaime Eduardo Cecilio
Source: Schizophrenia Bulletin. Unidade: FMRP
Subjects: TÉCNICA DELPHI, ESQUIZOFRENIA, TRANSTORNOS PSICÓTICOS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAGNER, Elias et al. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group. Schizophrenia Bulletin, v. 49, n. 4, p. 962-972, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbad030. Acesso em: 04 nov. 2024.
APA
Wagner, E., Siskind, D., Falkai, P., Howes, O., Correll, C., Lee, J., et al. (2023). Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group. Schizophrenia Bulletin, 49( 4), 962-972. doi:10.1093/schbul/sbad030
NLM
Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, Honer WG, Kane JM, Fernandez-Egea E, Barnes TRE, Hallak JEC. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group [Internet]. Schizophrenia Bulletin. 2023 ; 49( 4): 962-972.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1093/schbul/sbad030
Vancouver
Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, Honer WG, Kane JM, Fernandez-Egea E, Barnes TRE, Hallak JEC. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group [Internet]. Schizophrenia Bulletin. 2023 ; 49( 4): 962-972.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1093/schbul/sbad030
Artigo de periodico
Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats (2023)
Cavichioli, Andreza M.; Silva, Thamyris Santos; Grace, Anthony A.; Guimarães, Francisco Silveira ; Gomes, Felipe Villela
Source: Schizophrenia Bulletin. Unidade: FMRP
Subjects: POTENCIAIS DE AÇÃO, NEUROTRANSMISSORES, ESQUIZOFRENIA, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVICHIOLI, Andreza M. et al. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, v. 49, n. 1, p. 68-77, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbac106. Acesso em: 04 nov. 2024.
APA
Cavichioli, A. M., Silva, T. S., Grace, A. A., Guimarães, F. S., & Gomes, F. V. (2023). Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, 49( 1), 68-77. doi:10.1093/schbul/sbac106
NLM
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1093/schbul/sbac106
Vancouver
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1093/schbul/sbac106
Artigo de periodico
What can we learn from animal models to study schizophrenia? (2022)
Crunfli, Fernanda ; Del Bel, Elaine Aparecida ; Gomes, Felipe Villela ; Teles, Caroline Brandão; Zuccoli, Giuliana S.; Chaves Filho, Adriano J. M.; Vieira, Gabriela Maciel ; Amaral, Danyelle Silva; Crippa, José Alexandre de Souza ; Pedrazzi, João Francisco Cordeiro; Macêdo, Danielle S.
Source: Advances in Experimental Medicine and Biology. Unidades: FMRP, FORP
Subjects: ESQUIZOFRENIA, MODELOS ANIMAIS, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, GLUTAMATOS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUNFLI, Fernanda et al. What can we learn from animal models to study schizophrenia?. Advances in Experimental Medicine and Biology, v. 1400, p. 15-33, 2022Tradução . . Disponível em: https://doi.org/10.1007/978-3-030-97182-3_2. Acesso em: 04 nov. 2024.
APA
Crunfli, F., Del Bel, E. A., Gomes, F. V., Teles, C. B., Zuccoli, G. S., Chaves Filho, A. J. M., et al. (2022). What can we learn from animal models to study schizophrenia? Advances in Experimental Medicine and Biology, 1400, 15-33. doi:10.1007/978-3-030-97182-3_2
NLM
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Vancouver
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Artigo de periodico
Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (2022)
Souza, Adriana de Jesus; Cortez, Isadora L.; Silva, Nicole R.; Pedrazzi, João Francisco Cordeiro; Domingos, Luana B.; Braga, Matheus Silva; Silva, Thamyris Santos; Del Bel, Elaine Aparecida ; Resstel, Leonardo Barbosa Moraes ; Li, Guanguan; Mian, Md Yeunus; Sharmin, Dishary; Guimarães, Francisco Silveira ; Cook, James M.; Gomes, Felipe Villela
Source: Behavioural Brain Research. Unidades: FORP, FMRP
Subjects: ANSIEDADE, DEPRESSÃO, ANTIPSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Adriana de Jesus et al. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, v. 428, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2022.113832. Acesso em: 04 nov. 2024.
APA
Souza, A. de J., Cortez, I. L., Silva, N. R., Pedrazzi, J. F. C., Domingos, L. B., Braga, M. S., et al. (2022). Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, 428, 1-11. doi:10.1016/j.bbr.2022.113832
NLM
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Vancouver
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Artigo de periodico
Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention (2022)
Uliana, Daniela L.; Zhu, Xiyu; Gomes, Felipe Villela ; Grace, Anthony A.
Source: Frontiers in Behavioral Neuroscience. Unidade: FMRP
Subjects: DEPRESSÃO, NEUROTRANSMISSORES, PLASTICIDADE NEURONAL, CÓRTEX PRÉ-FRONTAL, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. et al. Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention. Frontiers in Behavioral Neuroscience, v. 16, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fnbeh.2022.935320. Acesso em: 04 nov. 2024.
APA
Uliana, D. L., Zhu, X., Gomes, F. V., & Grace, A. A. (2022). Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention. Frontiers in Behavioral Neuroscience, 16, 1-15. doi:10.3389/fnbeh.2022.935320
NLM
Uliana DL, Zhu X, Gomes FV, Grace AA. Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention [Internet]. Frontiers in Behavioral Neuroscience. 2022 ; 16 1-15.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3389/fnbeh.2022.935320
Vancouver
Uliana DL, Zhu X, Gomes FV, Grace AA. Using animal models for the studies of schizophrenia and depression: the value of translational models for treatment and prevention [Internet]. Frontiers in Behavioral Neuroscience. 2022 ; 16 1-15.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3389/fnbeh.2022.935320
Artigo de periodico
Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis (2022)
Gomes, Felipe Villela
Source: Biological Psychiatry. Unidade: FMRP
Subjects: HIPOCAMPO, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis. Biological Psychiatry, v. 91, n. 2, p. e7-e9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.biopsych.2021.10.019. Acesso em: 04 nov. 2024.
APA
Gomes, F. V. (2022). Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis. Biological Psychiatry, 91( 2), e7-e9. doi:10.1016/j.biopsych.2021.10.019
NLM
Gomes FV. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis [Internet]. Biological Psychiatry. 2022 ; 91( 2): e7-e9.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.biopsych.2021.10.019
Vancouver
Gomes FV. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis [Internet]. Biological Psychiatry. 2022 ; 91( 2): e7-e9.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.biopsych.2021.10.019
Artigo de periodico
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia (2022)
Cortez, Isadora Lopes; Silva, Nicole R.; Rodrigues, Naielly S.; Pedrazzi, João Francisco Cordeiro; Del Bel, Elaine Aparecida ; Mechoulam, Raphael; Gomes, Felipe Villela ; Guimarães, Francisco Silveira
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FORP, FMRP
Subjects: CANABINOIDES, ESQUIZOFRENIA, FARMACOTERAPIA, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Isadora Lopes et al. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 117, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2022.110553. Acesso em: 04 nov. 2024.
APA
Cortez, I. L., Silva, N. R., Rodrigues, N. S., Pedrazzi, J. F. C., Del Bel, E. A., Mechoulam, R., et al. (2022). HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 1-9. doi:10.1016/j.pnpbp.2022.110553
NLM
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Vancouver
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Artigo de periodico
GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia (2022)
Kiemes, Amanda; Gomes, Felipe Villela ; Cash, Diana; Uliana, Daniela L.; Simmons, Camilla; Singh, Nisha; Vernon, Anthony C.; Turkheimer, Federico; Davies, Cathy; Stone, James M.; Grace, Anthony A.; Modinos, Gemma
Source: Neuropsychopharmacology. Unidade: FMRP
Subjects: MODELOS ANIMAIS DE DOENÇAS, HIPOCAMPO, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIEMES, Amanda et al. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, v. 47, n. 3, p. 687-695, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41386-021-01213-0. Acesso em: 04 nov. 2024.
APA
Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., et al. (2022). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, 47( 3), 687-695. doi:10.1038/s41386-021-01213-0
NLM
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
Vancouver
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
Artigo de periodico
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls (2021)
Sami, Musa; Quattrone, Diego; Ferraro, Laura; Tripoli, Giada; Cascia, Erika La; Gayer-Anderson, Charlotte; Selten, Jean-Paul; Arango, Celso; Bernardo, Miquel; Tarricone, Ilaria; Tortelli, Andrea; Del-Ben, Cristina Marta
Source: Psychological Medicine. Unidade: FMRP
Subjects: ESQUIZOFRENIA, FÁRMACOS, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMI, Musa et al. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls. Psychological Medicine, v. 51, n. 12, p. 2074-2082, 2021Tradução . . Disponível em: https://doi.org/10.1017/S0033291720000847. Acesso em: 04 nov. 2024.
APA
Sami, M., Quattrone, D., Ferraro, L., Tripoli, G., Cascia, E. L., Gayer-Anderson, C., et al. (2021). Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls. Psychological Medicine, 51( 12), 2074-2082. doi:10.1017/S0033291720000847
NLM
Sami M, Quattrone D, Ferraro L, Tripoli G, Cascia EL, Gayer-Anderson C, Selten J-P, Arango C, Bernardo M, Tarricone I, Tortelli A, Del-Ben CM. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls [Internet]. Psychological Medicine. 2021 ; 51( 12): 2074-2082.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1017/S0033291720000847
Vancouver
Sami M, Quattrone D, Ferraro L, Tripoli G, Cascia EL, Gayer-Anderson C, Selten J-P, Arango C, Bernardo M, Tarricone I, Tortelli A, Del-Ben CM. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls [Internet]. Psychological Medicine. 2021 ; 51( 12): 2074-2082.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1017/S0033291720000847
Artigo de periodico
Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial (2021)
Guimarães, Tiago Moraes; Guimarães, Mara R. C.; Oliveira, Ícaro A. F.; Leoni, Renata Ferranti ; Santos, Antonio Carlos dos ; Dursun, Serdar M.; Crippa, José Alexandre de Souza ; Bressan, Rodrigo A.; Machado-de-Sousa, João Paulo ; Lacerda, Acioly L. T.; Hallak, Jaime Eduardo Cecilio
Source: Journal of Clinical Psychopharmacology. Unidades: FFCLRP, FMRP
Subjects: ANTIPSICÓTICOS, MÉTODO DUPLO-CEGO, FARMACOTERAPIA, ESQUIZOFRENIA, RESULTADO DE TRATAMENTO, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Tiago Moraes et al. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, v. 41, n. 3, p. 260-266, 2021Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001388. Acesso em: 04 nov. 2024.
APA
Guimarães, T. M., Guimarães, M. R. C., Oliveira, Í. A. F., Leoni, R. F., Santos, A. C. dos, Dursun, S. M., et al. (2021). Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, 41( 3), 260-266. doi:10.1097/JCP.0000000000001388
NLM
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1097/JCP.0000000000001388
Vancouver
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1097/JCP.0000000000001388
Artigo de periodico
Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification (2021)
Rosa, Pedro Gomes Penteado; Zugman, Andre; Cerqueira, Carlos Toledo; Serpa, Mauricio Henriques ; Duran, Fábio Luís de Souza; Zanetti, Marcus Vinicius; Bassitt, Débora Pastore; Elkis, Helio ; Crippa, José Alexandre de Souza ; Sallet, Paulo Clemente; Gattaz, Wagner Farid ; Hallak, Jaime Eduardo Cecilio ; Louzã Neto, Mario Rodrigues; Gadelha, Ary; Jackowski, Andrea Parolin; Bressan, Rodrigo Affonseca; Busatto Filho, Geraldo
Source: Schizophrenia Research. Unidades: FM, FMRP
Subjects: TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, ANTIPSICÓTICOS, CÓRTEX CEREBRAL, DIAGNÓSTICO POR IMAGEM, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA, Pedro Gomes Penteado et al. Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification. Schizophrenia Research, v. 236, p. 104-114, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2021.08.011. Acesso em: 04 nov. 2024.
APA
Rosa, P. G. P., Zugman, A., Cerqueira, C. T., Serpa, M. H., Duran, F. L. de S., Zanetti, M. V., et al. (2021). Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification. Schizophrenia Research, 236, 104-114. doi:10.1016/j.schres.2021.08.011
NLM
Rosa PGP, Zugman A, Cerqueira CT, Serpa MH, Duran FL de S, Zanetti MV, Bassitt DP, Elkis H, Crippa JA de S, Sallet PC, Gattaz WF, Hallak JEC, Louzã Neto MR, Gadelha A, Jackowski AP, Bressan RA, Busatto Filho G. Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification [Internet]. Schizophrenia Research. 2021 ; 236 104-114.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.schres.2021.08.011
Vancouver
Rosa PGP, Zugman A, Cerqueira CT, Serpa MH, Duran FL de S, Zanetti MV, Bassitt DP, Elkis H, Crippa JA de S, Sallet PC, Gattaz WF, Hallak JEC, Louzã Neto MR, Gadelha A, Jackowski AP, Bressan RA, Busatto Filho G. Cortical surface abnormalities are different depending on the stage of schizophrenia: a cross-sectional vertexwise mega-analysis of thickness, area and gyrification [Internet]. Schizophrenia Research. 2021 ; 236 104-114.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.schres.2021.08.011
Artigo de periodico
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum (2021)
Pedrazzi, João Francisco Cordeiro; Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Joca, Sâmia Regiane Lourenço ; Crippa, José Alexandre de Souza ; Del Bel, Elaine Aparecida
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FMRP, FCFRP, FORP
Subjects: ANFETAMINAS, ANTIPSICÓTICOS, COMPORTAMENTO ANIMAL, CANABINOIDES, METILAÇÃO DE DNA, CÓRTEX PRÉ-FRONTAL, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 111, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2021.110352. Acesso em: 04 nov. 2024.
APA
Pedrazzi, J. F. C., Sales, A. J., Guimarães, F. S., Joca, S. R. L., Crippa, J. A. de S., & Del Bel, E. A. (2021). Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111. doi:10.1016/j.pnpbp.2021.110352
NLM
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Vancouver
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Artigo de periodico
Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia (2020)
Sonnenschein, Susan F.; Gomes, Felipe Villela ; Grace, Anthony A.
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: NEUROTRANSMISSORES, HIPOCAMPO, CÓRTEX PRÉ-FRONTAL, TÁLAMO, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONNENSCHEIN, Susan F. e GOMES, Felipe Villela e GRACE, Anthony A. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Frontiers in Psychiatry, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2020.00613. Acesso em: 04 nov. 2024.
APA
Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020). Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Frontiers in Psychiatry, 11. doi:10.3389/fpsyt.2020.00613
NLM
Sonnenschein SF, Gomes FV, Grace AA. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 nov. 04 ] Available from: https://doi.org/10.3389/fpsyt.2020.00613
Vancouver
Sonnenschein SF, Gomes FV, Grace AA. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 nov. 04 ] Available from: https://doi.org/10.3389/fpsyt.2020.00613
Artigo de periodico
Restricted access carbon nanotube for microextraction by packed sorbent to determine antipsychotics in plasma samples by high-performance liquid chromatography-tandem mass spectrometry (2020)
Cruz, Jonas Carneiro ; Faria, Henrique Dipe de; Figueiredo, Eduardo Costa de; Queiroz, Maria Eugênia Costa
Source: Analytical and Bioanalytical Chemistry. Unidade: FFCLRP
Subjects: ANTIPSICÓTICOS, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, NANOTUBOS DE CARBONO, ESQUIZOFRENIA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Jonas Carneiro et al. Restricted access carbon nanotube for microextraction by packed sorbent to determine antipsychotics in plasma samples by high-performance liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry, v. 412, n. 11, p. 2465-2475, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00216-020-02464-4. Acesso em: 04 nov. 2024.
APA
Cruz, J. C., Faria, H. D. de, Figueiredo, E. C. de, & Queiroz, M. E. C. (2020). Restricted access carbon nanotube for microextraction by packed sorbent to determine antipsychotics in plasma samples by high-performance liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry, 412( 11), 2465-2475. doi:10.1007/s00216-020-02464-4
NLM
Cruz JC, Faria HD de, Figueiredo EC de, Queiroz MEC. Restricted access carbon nanotube for microextraction by packed sorbent to determine antipsychotics in plasma samples by high-performance liquid chromatography-tandem mass spectrometry [Internet]. Analytical and Bioanalytical Chemistry. 2020 ; 412( 11): 2465-2475.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s00216-020-02464-4
Vancouver
Cruz JC, Faria HD de, Figueiredo EC de, Queiroz MEC. Restricted access carbon nanotube for microextraction by packed sorbent to determine antipsychotics in plasma samples by high-performance liquid chromatography-tandem mass spectrometry [Internet]. Analytical and Bioanalytical Chemistry. 2020 ; 412( 11): 2465-2475.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s00216-020-02464-4
Artigo de periodico
GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function (2019)
Fachim, Helene Aparecida; Loureiro, Camila Marcelino ; Zuelli, Fabiana Maria das Graças Corsi ; Shuhama, Rosana ; Louzada Júnior, Paulo ; Menezes, Paulo Rossi ; Dalton, Caroline F.; Del-Ben, Cristina Marta ; Reynolds, Gavin P.
Source: Epigenomics. Unidades: FMRP, FM
Subjects: CONHECIMENTO, COGNIÇÃO, METILAÇÃO DE DNA, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FACHIM, Helene Aparecida et al. GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function. Epigenomics, v. 11, n. 4, p. 401-410, 2019Tradução . . Disponível em: https://doi.org/10.2217/epi-2018-0127. Acesso em: 04 nov. 2024.
APA
Fachim, H. A., Loureiro, C. M., Zuelli, F. M. das G. C., Shuhama, R., Louzada Júnior, P., Menezes, P. R., et al. (2019). GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function. Epigenomics, 11( 4), 401-410. doi:10.2217/epi-2018-0127
NLM
Fachim HA, Loureiro CM, Zuelli FM das GC, Shuhama R, Louzada Júnior P, Menezes PR, Dalton CF, Del-Ben CM, Reynolds GP. GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function [Internet]. Epigenomics. 2019 ; 11( 4): 401-410.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/epi-2018-0127
Vancouver
Fachim HA, Loureiro CM, Zuelli FM das GC, Shuhama R, Louzada Júnior P, Menezes PR, Dalton CF, Del-Ben CM, Reynolds GP. GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function [Internet]. Epigenomics. 2019 ; 11( 4): 401-410.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/epi-2018-0127
Artigo de periodico
Expressed emotion and socio-demographic and clinical factors in families of Brazilian patients with schizophrenia (2019)
Zanetti, Ana Carolina Guidorizzi ; Vedana, Kelly Graziani Giacchero ; Pereira, Camila Corrêa Matias; Marques, João Mazzoncini de Azevedo; Silva, Amanda Heloisa Santana da; Martin, Isabela dos Santos; Dantas, Rosana Aparecida Spadoti ; Souza, Jacqueline de ; Galera, Sueli Aparecida Frari ; Donato, Edilaine Cristina da Silva Gherardi
Source: International Journal of Social Psychiatry. Unidades: EERP, FMRP
Subjects: EMOÇÕES, TRANSTORNOS MENTAIS, ESQUIZOFRENIA, FAMÍLIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Ana Carolina Guidorizzi et al. Expressed emotion and socio-demographic and clinical factors in families of Brazilian patients with schizophrenia. International Journal of Social Psychiatry, v. 65, n. 1, p. 56-63, 2019Tradução . . Disponível em: https://doi.org/10.1177/0020764018815207. Acesso em: 04 nov. 2024.
APA
Zanetti, A. C. G., Vedana, K. G. G., Pereira, C. C. M., Marques, J. M. de A., Silva, A. H. S. da, Martin, I. dos S., et al. (2019). Expressed emotion and socio-demographic and clinical factors in families of Brazilian patients with schizophrenia. International Journal of Social Psychiatry, 65( 1), 56-63. doi:10.1177/0020764018815207
NLM
Zanetti ACG, Vedana KGG, Pereira CCM, Marques JM de A, Silva AHS da, Martin I dos S, Dantas RAS, Souza J de, Galera SAF, Donato EC da SG. Expressed emotion and socio-demographic and clinical factors in families of Brazilian patients with schizophrenia [Internet]. International Journal of Social Psychiatry. 2019 ; 65( 1): 56-63.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1177/0020764018815207
Vancouver
Zanetti ACG, Vedana KGG, Pereira CCM, Marques JM de A, Silva AHS da, Martin I dos S, Dantas RAS, Souza J de, Galera SAF, Donato EC da SG. Expressed emotion and socio-demographic and clinical factors in families of Brazilian patients with schizophrenia [Internet]. International Journal of Social Psychiatry. 2019 ; 65( 1): 56-63.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1177/0020764018815207
Artigo de periodico
Urbanicity and risk of first-episode psychosis: incidence study in Brazil (2019)
Del-Ben, Cristina Marta ; Shuhama, Rosana ; Loureiro, Camila Marcelino ; Ragazzi, Taciana Cristina Carvalho; Zanatta, Daniela Perocco; Tenan, Silvia Helena Galo; Santos, Jair Lício Ferreira ; Louzada Júnior, Paulo ; Santos, Antonio Carlos dos ; Morgan, Craig; Menezes, Paulo Rossi
Source: British Journal of Psychiatry. Unidades: FMRP, FM
Subjects: ESQUIZOFRENIA, INCIDÊNCIA, ZONA RURAL, ZONA URBANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEL-BEN, Cristina Marta et al. Urbanicity and risk of first-episode psychosis: incidence study in Brazil. British Journal of Psychiatry, v. 215, n. 6, p. 726-729, 2019Tradução . . Disponível em: https://doi.org/10.1192/bjp.2019.110. Acesso em: 04 nov. 2024.
APA
Del-Ben, C. M., Shuhama, R., Loureiro, C. M., Ragazzi, T. C. C., Zanatta, D. P., Tenan, S. H. G., et al. (2019). Urbanicity and risk of first-episode psychosis: incidence study in Brazil. British Journal of Psychiatry, 215( 6), 726-729. doi:10.1192/bjp.2019.110
NLM
Del-Ben CM, Shuhama R, Loureiro CM, Ragazzi TCC, Zanatta DP, Tenan SHG, Santos JLF, Louzada Júnior P, Santos AC dos, Morgan C, Menezes PR. Urbanicity and risk of first-episode psychosis: incidence study in Brazil [Internet]. British Journal of Psychiatry. 2019 ; 215( 6): 726-729.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1192/bjp.2019.110
Vancouver
Del-Ben CM, Shuhama R, Loureiro CM, Ragazzi TCC, Zanatta DP, Tenan SHG, Santos JLF, Louzada Júnior P, Santos AC dos, Morgan C, Menezes PR. Urbanicity and risk of first-episode psychosis: incidence study in Brazil [Internet]. British Journal of Psychiatry. 2019 ; 215( 6): 726-729.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1192/bjp.2019.110
Artigo de periodico
Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity (2018)
Uliana, Daniela L.; Resstel, Leonardo Barbosa Moraes; Grace, Anthony A.
Source: Neuropsychopharmacology. Unidade: FMRP
Subjects: MEDO, ESQUIZOFRENIA, ROEDORES, NEUROFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. e RESSTEL, Leonardo Barbosa Moraes e GRACE, Anthony A. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity. Neuropsychopharmacology, v. 43, n. 12, p. 2459-2467, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41386-018-0128-3. Acesso em: 04 nov. 2024.
APA
Uliana, D. L., Resstel, L. B. M., & Grace, A. A. (2018). Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity. Neuropsychopharmacology, 43( 12), 2459-2467. doi:10.1038/s41386-018-0128-3
NLM
Uliana DL, Resstel LBM, Grace AA. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity [Internet]. Neuropsychopharmacology. 2018 ; 43( 12): 2459-2467.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41386-018-0128-3
Vancouver
Uliana DL, Resstel LBM, Grace AA. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity [Internet]. Neuropsychopharmacology. 2018 ; 43( 12): 2459-2467.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/s41386-018-0128-3
Artigo de periodico
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia (2018)
Gomes, Felipe Villela ; Edelson, Jessica R.; Volk, David W.; Grace, Anthony A.
Source: Schizophrenia Research. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, CÉREBRO, CRESCIMENTO E DESENVOLVIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela et al. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, v. 201, p. 254-260, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2018.04.030. Acesso em: 04 nov. 2024.
APA
Gomes, F. V., Edelson, J. R., Volk, D. W., & Grace, A. A. (2018). Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, 201, 254-260. doi:10.1016/j.schres.2018.04.030
NLM
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Vancouver
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration